Healthcare -
Biotechnology - NASDAQ - US
$ 1.685
0 %
$ 10.2 M
Market Cap
-0.14
P/E
BTAI - LONG-TERM DEBT
Long-term Debt BTAI - BioXcel Therapeutics, Inc.
103 M
LAST VALUE
4.12%
2 YEAR CAGR
151.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR